ADDEX THERAPEUTICS LTD - AMERICAN DEPOSITARY SHARES

ADDEX THERAPEUTICS LTD - AMERICAN DEPOSITARY SHARES

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; a... nd GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - American Depositary Shares_logo

Industry:
Company

Address:
Chemin Des Mines, 9, Geneva, Switzerland Zipcode 1202

Country:
Switzerland

Phone:
41 22 884 1555

Market Cap:
60.79M
Total Revenue:
3.88M
Total Assets:
20.18M
Total Cash:
18.7M

Subsidiaries: Addex Pharma SA · Addex Pharmaceuticals France SAS


Key Executives
Name Title Pay Year Born
Mr. Timothy Mark Dyer Co-Founder, CEO & Director 623,225$ 1968(52 years old)
Mr. Lénaic Teyssédou Head of Fin. N/A 1986(34 years old)
Dr. Jean-Philippe Rocher Ph.D. Head of Discovery - Chemistry N/A 1959(61 years old)
Dr. Robert Lütjens Head of Discovery - Biology N/A 1968(52 years old)
Dr. Roger G. Mills M.D. Chief Medical Officer & Director N/A 1957(63 years old)
Dr. Werner Henrichi Ph.D. Consultant N/A 1943(77 years old)



Financial & Stock
Company's stock symbol is ADXN. Lastest price : 10.11. Total volume :4.86k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.addextherapeutics.com

  • Host name: od-d1e2fa.infomaniak.ch
  • IP address: 83.166.152.52
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...
Loading ...


More informations about "Addex Therapeutics Ltd - American Depositary Shares" on Search Engine

Addex Therapeutics Ltd American Depositary Shares (ADXN)

Nasdaq.com Addex Therapeutics Ltd American Depositary Shares (ADXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Addex Therapeutics Ltd American Depositary Shares (ADXN)

Nasdaq.com Addex Therapeutics Ltd American Depositary Shares (ADXN) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

ADXN - Addex Therapeutics Ltd - American Depositary Shares

Benzinga.com Jan 01, 2010 · Addex Therapeutics Ltd - American Depositary Shares ADXN:NASDAQ ... Shares Trading Up 120% in Premarket Charles Gross Thu, 21 Jan 2021 05:28:45 -0500 {{ story.title }} ...

Addex Therapeutics Ltd American Depositary Shares (ADXN)

Nasdaq.com Find the latest Earnings Report Date for Addex Therapeutics Ltd American Depositary Shares (ADXN) at Nasdaq.com.

Addex Therapeutics Ltd American Depositary Shares (ADXN)

Nasdaq.com Mar 11, 2021 · Find the latest press releases from Addex Therapeutics Ltd American Depositary Shares (ADXN) at Nasdaq.com.

Addex Starts Trading American Depositary Shares on Nasdaq

Addextherapeutics.com Jan 29, 2020 · Geneva, Switzerland, January 29, 2020 -- Addex Therapeutics Ltd (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced the listing of American Depositary Shares (ADSs) representing its ordinary shares on the Nasdaq Stock Market and the declaration by the United States Securities and …

Addex therapeutics :: Stock Data

Addextherapeutics.com Addex shares trade on the SIX Swiss Exchange main board under the stock symbol ADXN (ISIN: CH0029850754). Currently there are 39,748,635 shares (including treasury shares) outstanding. Addex American Depository Shares (ADS) representing 6 shares trade on the NASDAQ under the stock symbol ADXN. Current Addex Share Price - SIX

Addex Starts Trading American Depositary Shares on Nasdaq

Globenewswire.com Jan 29, 2020 · Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of …

Addex therapeutics :: Investors

Addextherapeutics.com Addex shares trade on the SIX Swiss Exchange main board under the stock symbol ADXN (ISIN: CH0029850754). Currently there are 39,748,635 shares (including treasury shares) outstanding. Addex American Depository Shares (ADS) representing 6 shares trade …

Addex therapeutics :: EN

Addextherapeutics.com Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Pipeline. Clinical and Pre-Clinical Pipeline Publications

Addex Starts Trading American Depositary Shares on Nasdaq

Finance.yahoo.com Geneva, Switzerland, January 29, 2020 -- Addex Therapeutics Ltd (ADXN.SW), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug …

Addex Files Registration Statement on Form F-3 with the US

Benzinga.com Apr 08, 2021 · Geneva, Switzerland, April 8, 2021 – Addex Therapeutics Ltd (NASDAQ:ADXN), ... including those to be settled in the form of American Depositary Shares (ADSs). Each ADS represents the …

Addex Therapeutics: Addex Starts Trading American

Bloomberg.com Jan 29, 2020 · Addex Therapeutics: Addex Starts Trading American Depositary Shares on Nasdaq Under Ticker ADXN. January 29, 2020, 1:00 AM EST ... 2020 -- Addex Therapeutics Ltd (SIX: ADXN), a clinical-stage ...

Addex therapeutics :: Addex Announces Filing of

Addextherapeutics.com Dec 14, 2020 · Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities. Geneva, Switzerland, December 14, 2020 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development announced today that it has filed a registration statement with the U.S. …

ADXN.OQ - Addex Therapeutics Ltd Profile | Reuters

Reuters.com BRIEF-Addex Therapeutics applies to list American Depositary Shares on the Nasdaq * ADDEX THERAPEUTICS LTD - HAVE APPLIED TO LIST ADSS, EACH REPRESENTING SIX SHARES OF CO ON THE NASDAQ STOCK ...

BRIEF-Addex Therapeutics applies to list American

Reuters.com * ADDEX THERAPEUTICS LTD - HAVE APPLIED TO LIST ADSS, EACH REPRESENTING SIX SHARES OF CO ON THE NASDAQ STOCK MARKET, OR NASDAQ, UNDER THE SYMBOL "ADXN." Source : (https://bit.ly/2YXgVr6) Further ...

Addex Files Registration Statement on Form F-3 with the US

Globenewswire.com Apr 08, 2021 · Geneva, Switzerland, April 8, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug …

ADXN Stock Price Quote & News - Addex Therapeutics | Robinhood

Robinhood.com Addex Therapeutics Ltd American Depositary Shares, also called Addex Therapeutics, is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders.

Addex Announces Pricing of $10.0 Million Global Offering

Globenewswire.com Jan 07, 2021 · Geneva, Switzerland, January 7, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based …

Securities Registration (foreign Private Issuer) (f-3)

Ih.advfn.com Apr 07, 2021 · This prospectus will allow us to issue shares from time to time at prices and terms to be determined in each offering up to a maximum aggregate offering price of $150,000,000. Each share may be issued in the form of American Depositary Shares or ADSs. Each ADS represents the right to receive six shares of Addex Therapeutics Ltd.

Addex Therapeutics Ltd ADR (ADXN) Recent Earnings

Earningswhispers.com Mar 11, 2021 · Addex Therapeutics Ltd ADR (ADXN) reported a Quarter December 2020 loss of $0.53 per share on revenue of $2.1 million.. Addex Therapeutics Ltd ADR (ADXN) reported a Quarter December 2020 loss of $0.53 per share on revenue of $2.1 million.. ... Listed American Depositary Shares (ADS) representing our ordinary shares on the Nasdaq Stock Market on ...

Addex therapeutics ltd - american depositary shares | Company

Alphacompany.org addex therapeutics ltd - american depositary shares Home Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland.

Addex Successfully Completes $11.5 Million Capital

Finance.yahoo.com Jan 12, 2021 · Geneva, Switzerland, January 11, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based …

Addex Therapeutics Ltd lists American Depositary Shares

Caplaw.ch Mar 31, 2020 · On January 29, 2020, Addex Therapeutics Ltd (Addex) (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced the listing of American Depositary Shares (ADSs) representing its ordinary shares on the Nasdaq Stock Market.

Schedule 13D - SEC

Sec.gov Addex Therapeutics Ltd. (Name of Issuer) Shares, nominal value CHF 1.00 per share (represented by American Depositary Shares) (Title of Class of Securities) 00654J107 (CUSIP Number) Louis S. Citron, Esq. New Enterprise Associates. 1954 Greenspring Drive, Suite 600, Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone Number of Person

Citi Appointed as Depositary Bank for Addex Therapeutics

Bloomberg.com Jan 30, 2020 · Addex Therapeutics’ American Depositary Shares (“ADS”) trade on the Nasdaq Global Select Market under the symbol “ADXN”. Each ADS represents six ordinary shares of the company.

Addex Therapeutics Ltd - American Depositary Shares

Nordnet.fi Osta osaketta Addex Therapeutics Ltd - American Depositary Shares (ADXN). Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi

Addex Announces Pricing of $10.0 Million Global Offering

Marketwatch.com Jan 06, 2021 · Jan 06, 2021 (GLOBE NEWSWIRE via COMTEX) -- Geneva, Switzerland, January 7, 2021 - Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering ...

Form 6-K Addex Therapeutics Ltd. For: Jan 11

Streetinsider.com Addex Therapeutics Ltd ... (including 6,750,000 shares delivered in the form of 1,125,000 American Depositary Shares, or ADSs) on the Nadaq Capital Market at a price of approximately CHF1.47 per ...

EdgarFiling - SEC.gov | HOME

Sec.gov EXHIBIT 99.1. Addex Announces Pricing of $10.0 Million Global Offering. Geneva, Switzerland, January 7, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today the pricing of an underwritten global offering of 6,000,000 registered shares (the New Shares ...

Addex Therapeutics files to sell $10M of ADS (NASDAQ:ADXN)

Seekingalpha.com Dec 14, 2020 · Addex Therapeutics (ADXN +0.5%) has filed a registration statement for a proposed underwritten public offering of shares to settled in American Depositary Shares, …

Addex Announces Pricing of $10.0 Million Global Offering

Ih.advfn.com Geneva, Switzerland, January 7, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today the pricing of an underwritten global offering of 6,000,000 registered shares (the New Shares) (including shares in the form of American Depositary Shares, or ADSs) …

Citi Appointed as Depositary Bank for Addex Therapeutics

Finance.yahoo.com Citi, acting through Citibank N.A., has been appointed by Addex Therapeutics Ltd -- a clinical-stage pharmaceutical company -- to act as depositary bank for its American Depositary Receipt ("ADR ...

Citi Appointed as Depositary Bank for Addex Therapeutics

Businesswire.com Jan 30, 2020 · Addex Therapeutics’ American Depositary Shares (“ADS”) trade on the Nasdaq Global Select Market under the symbol “ADXN”. Each ADS represents six ordinary shares of the company.

Addex Files Registration Statement on Form F-3 with the US

Ca.movies.yahoo.com Geneva, Switzerland, April 8, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it has filed a registration statement on Form F-3 with the U.S. Securities and Exchange Commission (SEC) to provide flexibility for future offerings of shares, …

Addex Files Registration Statement on Form F-3 with the US

Marketwatch.com Apr 08, 2021 · The MarketWatch News Department was not involved in the creation of this content. Apr 08, 2021 (GLOBE NEWSWIRE via COMTEX) -- Geneva, Switzerland, April 8, 2021 - Addex Therapeutics Ltd (SIX: ADXN ...

Addex Therapeutics Limited (ADXN) CEO Tim Dyer on Q4 2020

Seekingalpha.com Mar 11, 2021 · Addex Therapeutics Limited (NASDAQ:ADXN) Q4 2020 Earnings Conference Call March 11, 2021, 10:00 AM ET Company Participants Tim Dyer - CEO Roger Mills - …

Addex Successfully Completes $11.5 Million Capital

Benzinga.com Jan 12, 2021 · Geneva, Switzerland, January 11, 2021 – Addex Therapeutics Ltd ... (New Shares) (including 6,750,000 shares delivered in the form of 1,125,000 American Depositary Shares, or …

Press Release : Addex Files Registration Statement on Form

Marketscreener.com Apr 08, 2021 · Geneva, Switzerland, April 8, 2021 -- Addex Therapeutics... | April 8, 2021

Addex Therapeutics Ltd - American Depositary Shares (ADXN)

Nordnet.dk Køb Addex Therapeutics Ltd - American Depositary Shares (ADXN) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid

Addex Files Registration Statement on Form F-3 with the US

Einnews.com Apr 08, 2021 · Geneva, Switzerland, April 8, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric

Addex Therapeutics: Addex Announces Pricing of $10.0

Bloomberg.com Jan 07, 2021 · Addex Therapeutics: Addex Announces Pricing of $10.0 Million Global Offering Geneva, Switzerland, January 7, 2021 – Addex Therapeutics Ltd (SIX: ADXN and …